Prof. Dr. Mehmet Hilmi Doğu is a hematologist practicing at Liv Hospital Ulus and Liv Hospital Bahçeşehir in Istanbul, Turkey, as listed by the hospital in 2026. He graduated from Ege University Faculty of Medicine in 2005, completed his internal medicine specialization at Pamukkale University in 2011, and qualified as a hematologist in 2014. He became an Associate Professor in 2018 and a Professor in 2023. His principal clinical interests include chronic leukemia, Hodgkin and non-Hodgkin lymphoma, multiple myeloma, and chronic myeloproliferative disorders. He has contributed to clinical research in hematologic malignancies, stem cell transplantation, and therapeutic apheresis and maintains an academic affiliation with İstinye University.
Education and Academic Qualifications
-
1999–2005: Medical degree, Ege University Faculty of Medicine, Turkey.
-
2006–2011: Internal Medicine specialization, Pamukkale University, Turkey.
-
2011–2014: Hematology subspecialty training, Pamukkale University, Turkey.
-
May 2014: ESCCA Summer School on Cytometry, Prague.
-
2018: Awarded the title of Associate Professor in Hematology.
-
2023: Awarded the title of Professor, as documented by the Turkish Society for Apheresis.
Areas of Interest
-
Chronic lymphocytic leukemia (CLL) diagnosis and treatment in Turkey.
-
Chronic myeloid leukemia (CML) management.
-
Hodgkin and non-Hodgkin lymphoma.
-
Multiple myeloma and plasma cell disorders.
-
Chronic myeloproliferative neoplasms.
-
Polycythemia vera.
-
Essential thrombocythemia.
-
Myelofibrosis.
-
Hematologic malignancy evaluation and follow-up.
-
Hematologic assessment of candidates for hematopoietic stem cell transplantation.
-
Anemia, platelet disorders, and abnormal blood count evaluation.